Please provide your email address to receive an email when new articles are posted on . The staging system used for neurotrophic keratopathy, or NK, is the Mackie classification from 1995 with recent ...
In this expert perspective from Hawaiian Eye 2026, Marguerite B. McDonald, MD, FACS, discusses the use of DefEYE’s Biovance 3L Ocular decellularized basement membrane for the treatment of neurotrophic ...
Oxervate is a prescription eye drop approved for the treatment of neurotrophic keratitis. It is suitable for adults and children ages two years and older. Oxervate is a brand-name prescription drug ...
ROCKVILLE, Md., April 13, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx" or "Company"), a clinical-stage drug development company focused on tissue protection, repair ...
KB801 is a redosable eye drop gene therapy designed to enable sustained, localized expression and secretion of nerve growth factor (NGF) by epithelial cells in the front of the eye for the treatment ...
ROCKVILLE, Md., July 18, 2022 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx" or "Company"), a clinical-stage drug development company focused on tissue protection, repair, ...
(MENAFN- GetNews) The Key Neurotrophic Keratitis Companies in the market include - Dompé Farmaceutici, BRIM Biotechnology, ReGenTree, LLC, Oyster Point Pharma, Inc., Syneos Health, Recordati Rare ...
PRINCETON, N.J., June 21, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results